FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2493042425> ?p ?o ?g. }

• W2493042425 endingPage "1425" @default.
• W2493042425 startingPage "1417" @default.
• W2493042425 abstract "Improvement of graft-versus-host disease prophylaxis remains an important goal in allogeneic hematopoietic stem cell transplantation. Based on reports of possibly preferential properties of sirolimus, we compared the standard regimen of cyclosporine and methotrexate (n=106) with a combination of tacrolimus and sirolimus (n=103) as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation in a prospective, open, randomized trial. The hypothesis was that the tacrolimus/sirolimus regimen would lead to less acute graft-versus-host disease and reduced transplant-related mortality. There was no significant difference in the cumulative incidence of acute graft-versus-host disease of grades II-IV (41% vs. 51%; P=0.19) or grades III-IV (13% vs. 7%; P=0.09) between the groups. Time to neutrophil engraftment (18 days vs. 17 days; P=0.24) was similar, but time to platelet engraftment was longer in cyclosporine/methotrexate patients (14 vs. 12 days; P<0.01). No significant differences in incidence of oropharyngeal mucositis, time to full donor chimerism, or number of cytomegalovirus infections were seen between the two treatment arms, and transplant-related toxicities were equally distributed. Triglyceride (P=0.005) and cholesterol (P=0.009) levels were higher in tacrolimus/sirolimus patients. Transplant-related mortality (18% vs. 12%; P=0.40) and 5-year overall survival (72% vs. 71%; P=0.71) were similar. Five-year relapse-free survival in patients with malignant diagnoses was 65% in the cyclosporine/methotrexate group and 63% in the tacrolimus/sirolimus group (P=0.73). We conclude that tacrolimus/sirolimus remains a valid and safe alternative to cyclosporine/methotrexate as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation, with comparable transplant-related outcomes. The trial was registered at clinicaltrials.gov identifier: 00993343." @default.
• W2493042425 created "2016-08-23" @default.
• W2493042425 creator A5003097876 @default.
• W2493042425 creator A5008700475 @default.
• W2493042425 creator A5024844871 @default.
• W2493042425 creator A5025253628 @default.
• W2493042425 creator A5029318700 @default.
• W2493042425 creator A5042060760 @default.
• W2493042425 creator A5079082437 @default.
• W2493042425 creator A5080055664 @default.
• W2493042425 creator A5091081498 @default.
• W2493042425 date "2016-08-04" @default.
• W2493042425 modified "2023-10-10" @default.
• W2493042425 title "A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation" @default.
• W2493042425 cites W1491993932 @default.
• W2493042425 cites W1866279600 @default.
• W2493042425 cites W1969157667 @default.
• W2493042425 cites W1969669283 @default.
• W2493042425 cites W1971426009 @default.
• W2493042425 cites W1975141436 @default.
• W2493042425 cites W1995090169 @default.
• W2493042425 cites W1996485480 @default.
• W2493042425 cites W2001895625 @default.
• W2493042425 cites W2008349138 @default.
• W2493042425 cites W2010665897 @default.
• W2493042425 cites W2014400250 @default.
• W2493042425 cites W2021312489 @default.
• W2493042425 cites W2022850278 @default.
• W2493042425 cites W2024327060 @default.
• W2493042425 cites W2027357824 @default.
• W2493042425 cites W2031809201 @default.
• W2493042425 cites W2044804132 @default.
• W2493042425 cites W2045979374 @default.
• W2493042425 cites W2047260189 @default.
• W2493042425 cites W2054671000 @default.
• W2493042425 cites W2055981604 @default.
• W2493042425 cites W2056278483 @default.
• W2493042425 cites W2064152041 @default.
• W2493042425 cites W2075614768 @default.
• W2493042425 cites W2077929272 @default.
• W2493042425 cites W2082814420 @default.
• W2493042425 cites W2085290177 @default.
• W2493042425 cites W2089739646 @default.
• W2493042425 cites W2091238370 @default.
• W2493042425 cites W2094150097 @default.
• W2493042425 cites W2095172457 @default.
• W2493042425 cites W2095306235 @default.
• W2493042425 cites W2106162503 @default.
• W2493042425 cites W2108420092 @default.
• W2493042425 cites W2117658362 @default.
• W2493042425 cites W2123368042 @default.
• W2493042425 cites W2127036836 @default.
• W2493042425 cites W2137960096 @default.
• W2493042425 cites W2144737390 @default.
• W2493042425 cites W2147425918 @default.
• W2493042425 cites W215523164 @default.
• W2493042425 cites W2163521262 @default.
• W2493042425 cites W2164885965 @default.
• W2493042425 cites W2379365975 @default.
• W2493042425 cites W2419118976 @default.
• W2493042425 cites W24911164 @default.
• W2493042425 cites W2618073389 @default.
• W2493042425 cites W303912468 @default.
• W2493042425 cites W66769540 @default.
• W2493042425 doi "https://doi.org/10.3324/haematol.2016.149294" @default.
• W2493042425 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5394879" @default.
• W2493042425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27662016" @default.
• W2493042425 hasPublicationYear "2016" @default.
• W2493042425 type Work @default.
• W2493042425 sameAs 2493042425 @default.
• W2493042425 citedByCount "52" @default.
• W2493042425 countsByYear W24930424252017 @default.
• W2493042425 countsByYear W24930424252018 @default.
• W2493042425 countsByYear W24930424252019 @default.
• W2493042425 countsByYear W24930424252020 @default.
• W2493042425 countsByYear W24930424252021 @default.
• W2493042425 countsByYear W24930424252022 @default.
• W2493042425 countsByYear W24930424252023 @default.
• W2493042425 crossrefType "journal-article" @default.
• W2493042425 hasAuthorship W2493042425A5003097876 @default.
• W2493042425 hasAuthorship W2493042425A5008700475 @default.
• W2493042425 hasAuthorship W2493042425A5024844871 @default.
• W2493042425 hasAuthorship W2493042425A5025253628 @default.
• W2493042425 hasAuthorship W2493042425A5029318700 @default.
• W2493042425 hasAuthorship W2493042425A5042060760 @default.
• W2493042425 hasAuthorship W2493042425A5079082437 @default.
• W2493042425 hasAuthorship W2493042425A5080055664 @default.
• W2493042425 hasAuthorship W2493042425A5091081498 @default.
• W2493042425 hasBestOaLocation W24930424251 @default.
• W2493042425 hasConcept C126322002 @default.
• W2493042425 hasConcept C128057223 @default.
• W2493042425 hasConcept C141071460 @default.
• W2493042425 hasConcept C2776694085 @default.
• W2493042425 hasConcept C2777408962 @default.
• W2493042425 hasConcept C2777921159 @default.
• W2493042425 hasConcept C2778496288 @default.
• W2493042425 hasConcept C2779972918 @default.
• W2493042425 hasConcept C2781059491 @default.

• next